The report provides a detailed analysis essential for establishing a Thiethylperazine production plant. It encompasses all critical aspects necessary for Thiethylperazine production, including the cost of Thiethylperazine production, Thiethylperazine plant cost, Thiethylperazine production costs, and the overall Thiethylperazine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Thiethylperazine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Thiethylperazine is a type of medicine from the phenothiazine family that blocks dopamine D2 receptors in the brain. It works as an antiemetic agent to control and reduce nausea and vomiting arising from various clinical conditions. It is used in postoperative recovery following anaesthesia and surgery and administered via deep intramuscular injection toward the end of procedures. Its mechanism of action involves blocking postsynaptic dopamine receptors within the brain's chemoreceptor trigger zone to interrupt vomiting signals.
It also exerts antagonistic effects on peripheral vagus nerve activity in the gastrointestinal tract, as well as influencing muscarinic, histamine H1, and alpha-1 adrenergic receptors.
The market for Thiethylperazine is driven by consistent demand in surgical, oncology, and toxin exposure settings. Its usage as an antiemetic agent in postoperative nausea, chemotherapy, and radiation therapy contributes to its market growth. The rising cancer treatments and procedures boost its market for managing nausea. The industrial Thiethylperazine procurement is affected by the presence of limited GMP-certified API manufacturers, suppliers, and exporters with USDMF or CEP approvals.
Also, regulatory compliance, quality certifications, and reliable global supply chains further impact its sourcing. Other factors, like careful formulation to avoid interactions (e.g., with antithyroid drugs), historical regulatory withdrawals of related phenothiazines, and research on dopaminergic side effects, add to procurement costs.
Raw Material for Thiethylperazine Production
Raw Material for Thiethylperazine Production
According to the Thiethylperazine production plant project report, the key raw materials used in the production of Thiethylperazine include (Ethylmercapto-Phenothiazine)-Substituted Chloropropyl Piperazine-Sodium Amide-Xylene-Ammonium Chloride.
Production Process of Thiethylperazine
The extensive Thiethylperazine production cost report consists of the following major industrial production process:
- From Ethylmercapto-Phenothiazine Derivative: The production process of Thiethylperazine involves several steps. In this process, a phenothiazine derivative containing an ethylmercapto group is reacted with a piperazine compound bearing a chloropropyl substituent in the presence of a strong base in a hot aromatic solvent. The reaction mixture is heated under reflux conditions, then cooled, and the excess base is neutralised using an ammonium salt. The product is extracted into an acidic aqueous phase and subsequently basified to regenerate the free base, which is then extracted into an organic solvent. After drying, the crude product is purified by high-vacuum distillation to yield the Thiethylperazine base.
Thiethylperazine has a molecular formula of C22H29N3S2 and a molecular weight of 399.62 g/mol. It appears as a yellowish granular powder or light brown to grey solid and is odourless or with a slight odour. It has a melting point of 62-64 degree Celsius, a boiling point of 227 degree Celsius. It has a density of around 1.168 g/cm³ and, refractive index of approximately 1.5605. It has high lipophilicity (logP 5.04-5.41), low water solubility (0.0584 mg/L), and good solubility in DMSO up to 100 mg/ml. It has a pKa value of 7.66±0.10, zero hydrogen bond donors, a polar surface area of 9.72-60.32 Ų, and acts as a dopamine D2 and serotonin antagonist, with stability supporting its antiemetic applications.